Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share, Growth, Demand Analysis by Segmentation, Global Opportunities, Industry Trend and Regional Outlook 2019 to 2023

Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Share, Growth, Demand Analysis by Segmentation, Global Opportunities, Industry Trend and Regional Outlook 2019 to 2023

“Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market”
Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Growth, Size, Share and Trend Analysis By Drug Class (Sulfa Drugs, Tetracyclines, Oxazolidinones, Glycopeptide Antibiotics), MRSA Type (Hospital-Acquired (HA-MRSA), Community-Acquired), Disease Indications (Skin Infections), End User – Global Forecast till 2023

Methicillin-Resistant Staphylococcus Aureus (MRSA) is an antibiotic resistant strains of the pathogen. MRSA infections are classified as hospital-acquired (HA-MRSA) or community-acquired (CA-MRSA). MRSA causes infections such as skin infections, bone and joint infections, bacteremia, animal infections and others.

The global MRSA drugs market is expected to reach USD 4,312.2 million by 2023, and the market is projected to grow at a CAGR of ~ 4.4 % during the forecast period 2017-2023.

According to bulletin of the atomic scientists, about 10 million people in the US (3.6 percent of the population) are immune-compromised. The World Health Organization estimated that about 36.7 million people had HIV/AIDS worldwide in 2016. Additionally, growing geriatric population projected to support the growth of the market since older people are more susceptible to MRSA infections.  

Avail Sample Copy at https://www.marketresearchfuture.com/sample_request/2102

Key Findings:

  • Oxazolidinones segment commanded the largest market share in 2016 and is expected to reach USD 1,393.5 million by the end of 2023. Furthermore, Oxazolidinones segment is expected to be the fastest growing market, which is expected to grow at a CAGR of 5.1 % during the forecast period 2017-2023.
  • Hospital-acquired (HA-MRSA) segment commanded the largest market share in 2016. This market is expected to reach USD 2,709.5 million by 2023 at a CAGR of 4.0 % during the forecast period 2017-2023.
  • Skin infections segment commanded the largest market share in 2016. This market is expected to reach USD 1,208.3 million by 2023 at a CAGR of 4.5 % during the forecast period 2017-2023
  • North America commanded the largest market share in 2016. This market is expected to reach USD 1,602.5 million by 2023 at a CAGR of 4.6 % during the forecast period of 2017-2023 

MRSA Drugs Market Key Players:

Some of the key players profiled in the report are

  • Merck KGaA
  • Olon
  • Allergan
  • Baxter
  • Theravance Biopharma
  • Pfizer
  • Mylan N.V
  • Novartis
  • and others.

MRSA Drugs Market Segmentation:

The global MRSA drugs market has been segmented on the basis of drug class, MRSA types, disease indications, and end user.

Based on the drug class, the market has been segmented as sulfa drugs, tetracyclines, oxazolidinones, glycopeptide antibiotics, and other.

Based on the MRSA types, the market has been segmented as hospital-acquired (HA-MRSA) and community-acquired (CA-MRSA).

Based on the disease indications, the market has been segmented as skin infections, bone and joint infections, bacteremia, animal infections, and others.

Based on the end user, the market has been segmented as hospitals & clinics, academic and research, and others.

Browse Complete Premium Research Report at https://www.marketresearchfuture.com/reports/mrsa-drugs-market-2102

MRSA Regional Analysis:

The Americas accounts for a significant market share owing to high expenditure on the health care. The fastest uptake of new drugs in the US drives the MRSA drugs market.

Europe is the second largest market in the world due to high income and strong healthcare penetration. The European market growth is led by countries such as Germany and France.

Asia Pacific region is expected to grow rapidly; China and India are likely to lead this market due to the fast growing healthcare sector and large unmet needs over the forecast period.

Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. Other Middle East nations to watch out for are Kuwait, Jordan, Egypt and Iran

Table of Content

  1. Report Prologue
  2. Introduction
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis

5.1 Value Chain Analysis

5.2 PORTERS Five Forces

5.3 Demand & Supply: Gap Analysis

5.4 Pricing Analysis

5.5 Investment Opportunity Analysis

5.6 Merger And Acquisition Landscape

5.7 Upcoming Trends

5.7.1 Market Trends

5.7.2 Technological Trends

5.7.3 Insurance & Regulations

5.7.4 Others

  1. Scleritis Market By Types
  2. Scleritis Market By Treatment
  3. Scleritis Market By Region

…to be Continued.

Inquire for Exclusive discount at https://www.marketresearchfuture.com/check-discount/2102

About Market Research Future: Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/mrsa-drugs-market-2102